PhIP


CAS No. : 105650-23-5

(Synonyms: 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine)

105650-23-5
Price and Availability of CAS No. : 105650-23-5
Size Price Stock
5mg $140 In-stock
10mg $230 In-stock
25mg $500 In-stock
50mg $825 In-stock
100mg $1360 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-118716
M.Wt: 224.26
Formula: C13H12N4
Purity: >98 %
Solubility: DMSO : 25 mg/mL (ultrasonic;warming;heat to 60°C)
Introduction of 105650-23-5 :

PhIP (2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) is the most abundant of generation of heterocyclic amines (HCA), resulted in the cooking of meat[1][2]. DNA damaging and mutagenic activities. PhIP also has oestrogenic activity that could contribute to its tissue specific carcinogenicity[2]. In Vitro:PhIP causes widespread and largely over-lapping effects on miRNA expression. PhIP induces widespread effects via activation of oestrogen receptor alpha (ERα). Deregulation of miRNA by PhIP could potentially be an important non-DNA-damaging carcinogenic mechanism in breast cancer[2]. In Vivo:Note:
Please do not refer to only one article to determine the experimental conditions. It is recommended to determine the optimal experimental conditions (animal strain, age, dosage, frequency and cycle, detection time and indicators, etc.) through preliminary experiments before the formal experiment.

PhIP (400 p.p.m. in diet) induces colon carcinogenesis in male F344 rats, progressing through defined phases: PhIP-DNA adduct formation (peaking at 1-8 weeks), subsequent crypt cell hyperproliferation (4-12 weeks), and the emergence of preneoplastic aberrant crypt foci (ACF) by 14 weeks. This sequence, upon continuous exposure for 52 weeks, results in colon carcinomas at an incidence of about 50%[3][4]
PhIP (400 p.p.m. in diet), employing an intermittent high-fat regimen, efficiently induces colon carcinogenesis in male F344 rats, with an incidence of ~45% within 60 weeks[5].
PhIP (total dose 200 mg/kg, i.g.) induces the formation of small intestinal tumors at the ages of weeks 28-40 in obese hCYP1A-db/db mice[6].

Induction of colon cancer[3][4]
Background
PhIP is metabolically activated to form DNA adducts, which induce β-catenin mutations. These mutations drive β-catenin accumulation and crypt hyperproliferation, resulting in the sequential development of dysplastic ACF, adenomas, and ultimately, colon adenocarcinoma[3][4].
Specific Modeling Methods
1.Rats: F344 rats • male • 6-week-old
Administration: 400 p.p.m. in diet • p.o. • daily for 52 weeks;
2. Rats: F344 rats • male • maintained on a high-fat diet throughout • 6-week-old
Administration: 400 p.p.m. in diet • p.o. • 2 weeks, followed by 4 weeks of high-fat diet alone, the cycle repeated 3 times, followed by the high-fat diet for 42 weeks
Note
In Modeling Method 2: After completing the 3 cycles, animals continued on the high-fat diet alone for an additional 42 weeks.
Modeling Indicators
Molecular changes: PhIP-DNA adduct formation, β-Catenin mutation (e.g., at codon 34), cytoplasmic β-catenin accumulation, increased Ki-67 level
Cellular changes: Hyperproliferation of crypt epithelial cells
Histology analysis: Dysplastic ACF, Crypt distortion


Induction of small intestinal carcinogenesis[6]
Background
The combination of PhIP-induced Apc mutation and obesity-associated DNA hypermethylation silences Apc function, driving nuclear β-catenin accumulation, crypt hyperproliferation, and ultimately the formation of dysplastic tubular adenomas in the small intestine[6].
Specific Modeling Methods
Mice: hCYP1A-db/db mice • fed with AIN93M diet • 6 week-old
Administration: 100 mg/kg • i.g. • total 2 doses, 4 days apart, starting at 6 weeks of age.
Note
Mice were continuously maintained on the AIN93M diet until the termination of the experiment (28-40 weeks after the PhIP treatment).
Modeling Indicators
Molecular changes: Upregulation of NF-κB (p65), pSTAT3, and COX2 in small intestinal tumors; nuclear β-catenin accumulation
Cellular changes: Hyperproliferation of crypt epithelial cells
Histology analysis: tubular adenomas (with dysplasia), Crypt distortion


In hCYP1A-mice, PhIP induces inflammation, epithelial cell damage, and prostatic intraepithelial neoplasia in the dorsolateral prostate lobe compared to the ventral lobe. PhIP forms DNA adducts in the prostate, PhIP also induces oxidative stress, atrophy of the acini, and inflammation of the prostate of rodents[1].

Your information is safe with us.

Our product is for R&D purpose only.